| SomnoMed Limited (SOM) ORDINARY FULLY PAID |
Health Care |
$151 |
Quarterly Activities Report
|
29 Jul 2025 9:11AM |
$0.685 |
$0.690 |
risen by
0.73%
|
|
SOM - Price-sensitive ASX Announcement
Full Release
Key Points
- SomnoMed achieved record quarterly revenue in Q4 FY23, reflecting strong product demand.
- Significant growth occurred in North America and Europe, with both regions outperforming prior periods.
- The company expanded its product portfolio, successfully launching the SomnoDent® Avant™ device.
- Progress continued on the development and forthcoming global launch of the Rest Assure® sleep-monitoring device.
- SomnoMed invested in research, digital workflow improvements, and market education.
- The company strengthened partnerships with sleep physicians and dental professionals.
- Operational enhancements and investments in education and training were implemented.
- The company maintained a robust cash position to fund further growth and innovation initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Switzer Dividend Growth Fund (Managed Fund) (SWTZ) |
Financials |
$57 |
Distribution for month ending 31 July 2025
|
29 Jul 2025 9:10AM |
$2.470 |
$2.440 |
fallen by
1.21%
|
|
| Avecho Biotechnology Limited (AVE) ORDINARY FULLY PAID |
Health Care |
$40 |
Phase III Insomnia Trial Recruitment Update
|
29 Jul 2025 9:08AM |
$0.005 |
$0.011 |
risen by
144.44%
|
|
AVE - Price-sensitive ASX Announcement
Full Release
Key Points
- Avecho Biotechnology Limited provided an update on recruitment for its Phase III insomnia trial.
- The trial investigates TPM®/CBD, a novel oral cannabinoid product for insomnia.
- Recruitment was previously paused due to regulatory changes by the TGA allowing CBD as a pharmacist-only medicine.
- Avecho plans to resume recruitment and is revising the clinical protocol to align with new regulatory pathways.
- The company is engaging with clinical sites to fast-track the process.
- Resumption of recruitment aims to position Avecho’s product for over-the-counter registration in Australia.
- The market for effective insomnia treatments is large and currently underserved.
- Avecho remains focused on execution of the insomnia trial to support commercial objectives.
- Further updates will be provided as key milestones are achieved.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$412 |
Weekly NTA 25 July 2025
|
29 Jul 2025 9:08AM |
$1.885 |
$1.810 |
fallen by
3.98%
|
|
| Arafura Rare Earths Ltd (ARU) ORDINARY FULLY PAID |
Materials |
$1,350 |
Quarterly Activities Report and Appendix 5B
|
29 Jul 2025 9:07AM |
$0.180 |
$0.290 |
risen by
61.11%
|
|
ARU - Price-sensitive ASX Announcement
Full Release
Key Points
- Nolans Project engineering, procurement, and early construction activities progressed during the quarter.
- Company maintains a strong cash balance to support ongoing project development.
- Significant progress made on funding arrangements and offtake agreements with major international partners.
- Sustainability initiatives and community engagement remain core focuses for the project.
- Key project milestones include workforce expansion and advancing towards main construction.
- Appendix 5B provides a summary of cash flows and financial performance for the quarter.
- Company remains committed to timely project delivery and managing development risks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$27 |
Proposed issue of securities - PL3
|
29 Jul 2025 9:07AM |
$0.044 |
$0.130 |
risen by
195.45%
|
|
| Pacgold Limited (PGO) ORDINARY FULLY PAID |
Materials |
$56 |
Notification regarding unquoted securities - PGO
|
29 Jul 2025 9:03AM |
$0.063 |
$0.130 |
risen by
106.35%
|
|
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$102 |
Update - Notification of buy-back - TOP
|
29 Jul 2025 9:03AM |
$0.650 |
$0.600 |
fallen by
7.69%
|
|
| Pacgold Limited (PGO) ORDINARY FULLY PAID |
Materials |
$56 |
Notification regarding unquoted securities - PGO
|
29 Jul 2025 9:03AM |
$0.063 |
$0.130 |
risen by
106.35%
|
|
| Amaero Ltd (3DA) ORDINARY FULLY PAID |
Industrials |
$271 |
Notification regarding unquoted securities - 3DA
|
29 Jul 2025 9:03AM |
$0.520 |
$0.285 |
fallen by
45.19%
|
|
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$27 |
Fully Underwritten Entitlement Offer Prospectus
|
29 Jul 2025 9:03AM |
$0.044 |
$0.130 |
risen by
195.45%
|
|
PL3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Patagonia Lithium Ltd (PL3) is conducting a fully underwritten pro-rata non-renounceable entitlement offer to raise approximately $1.9 million.
- Eligible shareholders can acquire new shares and attaching options under the offer.
- Funds raised will be used for exploration and development of PL3's lithium projects in Argentina and for general working capital.
- The offer is fully underwritten by Westar Capital Limited, with the possibility of the underwriter and sub-underwriters increasing their shareholding.
- Significant risks include exploration and development risk, commodity price fluctuations, sovereign risk relating to Argentina, funding and dilution risks, and regulatory risks.
- The prospectus provides detailed instructions for participation, the timetable for the offer, and information on effect on control and capital structure.
- Directors and management have outlined their intentions regarding participation in the offer and disclosure of related party interests.
- Extensive legal, financial, and corporate governance disclosures are included.
- The offer aims to strengthen the company's financial position and support its ongoing lithium exploration strategy.
- The document is dated 6 June 2024 and is valid for 13 months.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,356 |
Update - Notification of buy-back - GNC
|
29 Jul 2025 9:03AM |
$7.500 |
$6.100 |
fallen by
18.67%
|
|
| Iltani Resources Limited (ILT) ORDINARY FULLY PAID |
Materials |
$38 |
ILT June 2025 Quarterly Activities Report & Appendix 5B
|
29 Jul 2025 9:03AM |
$0.220 |
$0.485 |
risen by
120.45%
|
|
ILT - Price-sensitive ASX Announcement
Full Release
Key Points
- Provided update on exploration activities and progress at key projects.
- Reported on drilling programs, assay results, and geological interpretations.
- Outlined updates on tenement holdings and corporate developments.
- Presented summary of financial status and cash flow for the quarter.
- Appendix 5B details cash inflow and outflow, especially on exploration and administrative expenditure.
- Confirmed continued investment in exploration aligned with strategic objectives.
- Highlighted prudent financial management during the reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tigers Realm Coal Limited (TIG) ORDINARY FULLY PAID |
Materials |
$39 |
2025 June Quarterly Report
|
29 Jul 2025 9:03AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$3 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 9:02AM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities/Appendix 4C Cash Flow Report for quarter ended 31 March 2024.
- Progress on development and licensing of ANR and the GaRP gastrointestinal health product.
- Ongoing engagement with potential partners for commercialization.
- Exploration of additional market opportunities for the GaRP product.
- Reported R&D, corporate, and administrative expenditures for the quarter.
- Closing cash balance provided, with a focus on financial sustainability.
- Received Australian Government R&D tax incentive.
- No major changes in business activities or financing arrangements during the quarter.
- Continued advancement of product pipeline and licensing discussions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nimy Resources Limited (NIM) ORDINARY FULLY PAID |
Materials |
$25 |
Gallium Resource Drilling Final Assays
|
29 Jul 2025 9:02AM |
$0.068 |
$0.072 |
risen by
5.88%
|
|
NIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Nimy Resources Limited completed a gallium resource drilling campaign at the Mons Project
- Final assays confirmed broad and continuous gallium mineralisation in multiple drill holes
- Gallium mineralisation is associated with nickel, cobalt, and scandium
- The drilling program targeted maiden resource definition for gallium and rare earth elements
- Results will support resource estimation and future development strategies
- Gallium is recognized as a critical mineral with strategic significance
- Next steps include resource modeling and metallurgical test work
- The company is positioned to contribute to the supply of critical minerals in Western Australia
- The report also references associated nickel mineralisation and potential economic upside
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vitasora Health Limited (VHL) ORDINARY FULLY PAID |
Health Care |
$43 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jul 2025 9:01AM |
$0.026 |
$0.022 |
fallen by
15.38%
|
|
VHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report for period ending 31 December 2023.
- Focus on integration and expansion of telehealth and digital health services.
- Progress in business development and strategic partnerships.
- Detailed cash flow statement including receipts, R&D, advertising, and administrative expenses.
- Emphasis on digital health platform enhancements.
- Future outlook includes continued market penetration and growth strategies.
- Commitment to increasing shareholder value through strategic initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$191 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jul 2025 9:00AM |
$0.140 |
$0.440 |
risen by
214.29%
|
|
ELT - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities report and Appendix 5B cash flow report for the period ended 31 March 2023.
- Oropesa Tin Project in Spain advanced with environmental permitting and DFS activities.
- Cleveland Tin Project in Tasmania continued progressing, focusing on project studies and tenement management.
- Ongoing engagement with local communities and regulatory authorities.
- Cash flows for the quarter outlined, including exploration, evaluation costs, and administration expenses.
- The company had sufficient cash reserves at the end of the quarter.
- Elementos Limited continues to prioritize advancing its tin projects and prudent financial management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Urbanise.Com Limited (UBN) ORDINARY FULLY PAID |
Information Technology |
$51 |
Appendix 4C and Quarterly Activities Report
|
29 Jul 2025 8:59AM |
$0.850 |
$0.650 |
fallen by
23.53%
|
|
UBN - Price-sensitive ASX Announcement
Full Release
Key Points
- Total cash receipts from customers were $3.9 million for the quarter.
- Net operating cash outflows were $0.4 million, reflecting continued investment in technology.
- Cash at the end of the quarter was $2.6 million.
- Recurring SaaS revenue remained strong, with key contracts renewed and new customers added.
- Ongoing cost management initiatives were implemented to improve operational efficiency.
- Product development efforts focused on platform enhancements for both strata and facilities management.
- The company updated on sales pipeline and opportunities for growth in its target markets.
- Urbanise.Com Limited is prioritizing technology advancement and customer engagement.
- No payments were made to related parties other than standard remuneration.
- The company maintains a positive outlook and continues to focus on strategic initiatives for future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$253 |
Quarterly Cashflow Report
|
29 Jul 2025 8:58AM |
$0.705 |
$1.060 |
risen by
50.35%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Major exploration progress achieved at Tarcoola and Tunkillia projects.
- Stage 2 drilling completed with significant gold intersections reported.
- Total gold mineralisation at Tunkillia almost doubled via updated Mineral Resource Estimate.
- Maiden Mineral Resource Estimate announced for the 223 Deposit.
- Regional exploration advanced with completion of geophysical surveys and further drilling approvals.
- The company ended the quarter with A$10.2 million cash at bank.
- Expenditures during the quarter focused on exploration and development; no production revenues reported.
- BGD continues to be well-funded for ongoing exploration and study programs.
- No mining or production activities occurred during the quarter.
- No payments were made to related parties except for director fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ausquest Limited (AQD) ORDINARY FULLY PAID |
Materials |
$70 |
RC Drilling locates more magnetite at Morrisey
|
29 Jul 2025 8:58AM |
$0.042 |
$0.043 |
risen by
2.38%
|
|
AQD - Price-sensitive ASX Announcement
Full Release
Key Points
- AusQuest Limited reported results from RC drilling at the Morrisey magnetite prospect.
- Drilling intersected significant zones of magnetite mineralization.
- The drilling extended the strike length of known magnetite mineralization.
- Magnetic surveys and drilling results indicate strong exploration potential.
- Further assay results from the drilling are pending.
- The results support the company’s ongoing strategy to develop its iron ore assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$428 |
Update - Notification of buy-back - RG8
|
29 Jul 2025 8:57AM |
$2.050 |
$2.950 |
risen by
43.90%
|
|
| Change Financial Limited (CCA) ORDINARY FULLY PAID |
Financials |
$72 |
Q4 FY25 Investor Presentation
|
29 Jul 2025 8:57AM |
$0.083 |
$0.105 |
risen by
26.51%
|
|
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$8 |
Notification of cessation of securities - ALV
|
29 Jul 2025 8:56AM |
$0.026 |
$0.032 |
risen by
23.08%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$253 |
Quarterly Activities Report
|
29 Jul 2025 8:56AM |
$0.705 |
$1.060 |
risen by
50.35%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced drilling operations at Tunkillia and Tarcoola Gold Projects.
- Reported positive results from drilling, including high-grade gold intersections.
- Updated Mineral Resource Estimates for Tunkillia and Tarcoola.
- Completed metallurgical testwork supporting project development.
- Engaged in stakeholder and investor communications.
- Maintained strong cash position and financial discipline.
- Outlined next steps including continued drilling, feasibility studies, and resource upgrades.
- Strengthened strategic positioning in South Australia's gold sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
